MedTrace Logo

GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education Programs

NCT01808066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2019-10-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine the use of, and reaction to, one particular software application(GroundsKeeper) delivered on unique platform - Sifteo cubes (www.sifteo.com). The hypothesis is that the use of these devices will increase engagement, motivation, interest, and have perceived benefits to users with unique attention-limiting cognitive disabilities. How does the observation of and user feedback from gameplay reveal areas of improvement for the game, strengths, and perceptions of value among the players and adults?

Conditions

  • Attention Deficit Hyperactivity Disorder
  • Autism Spectrum Disorder
  • Pervasive Developmental Disorder
  • Asperger's Disorder

Interventions

DEVICE

Groundskeeper

Groundskeeper is a product developed for helping players develop skills to increase focus and attention. The game is played on small Sifteo Cubes that have sensors that react to you and each other. There are new games that might help children with ADHD and Autism learn to better focus and keep attention on a task.

Sponsors & Collaborators

  • Ohio University

    collaborator OTHER

  • CogCubed, Corp

    lead INDUSTRY

Principal Investigators

  • Seann Dikkers, PhD · Ohio University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01808066 on ClinicalTrials.gov